Welcome to the World of Allergen-Specific Immunotherapy
This is the beginning of a new and exciting chapter. After its discovery 100 years ago Allergen-Specific Immunotherapy (ASIT) is entering a decade of fundamental regulatory changes, novel scientific data and - in general - great perspectives. No field of allergy has spiked more research ideas and clinical interest than the basics, modalities and practical applications of ASIT. The EAACI Interest Group Immunotherapy (IG IT) is going to prepare the European Allergy Community for further advancement of this unique approach to cope with IgE-mediated allergic reactions and diseases.
This part of the EAACI website will help to organize and inform about further activities of the EAACI IG Immunotherapy. The newly elected board is going to stimulate the interest of our members, clinicians and scientists, but also people from abroad to get involved in the fascinating path (not only past!) of Allergen-Specific Immunotherapy to the future.
Board 2011-2013
Chairperson
Moises Calderon
Head Of Clinical Trials Unit; Section of Allergy and Clinical Immunology. Royal Brompton Hospital. Imperial College; Dovehouse Street, London SW3 6LY
United Kingdom Phone +44 (0) 20 73 51 80 24 Mobil +44 (0) 78 12 56 74 35 Fax +44 (0) 20 73 49 77 80
m.calderon@imperial.ac.uk Secretary
Oliver Pfaar
Department of Otorhinolaryngology, Head and Neck Surgery Center for Rhinology and Allergology
An den Quellen 10,
D-65183 Wiesbaden, Germany
Phone: +49 611 308608 0
Fax: +49 611 308608 255
oliver.pfaar@hno-wiesbaden.de
Members:
Become an ambassador of Immunotherapy in your center and country!
JMA Affiliate
Paraskevi Mangina
viva6mag@yahoo.com
Webmasters
Pablo Rodríguez del Río
Email: prodriguezd@salud.madrid.org
Jörg Kleine-Tebbe
Email: kleine-tebbe@allergie-experten.de
Please address any comments and suggestions to the webmaster
|
